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ABSTRACT

Cell adhesion molecules mediate specific cell-cell interactions during
embryogenesis and tissue formation.

Among cell-cell adhesion molecules

(CAMs), we have been particularly interested in the neural cell adhesion
molecule (NCAM) which is the prototypical member of the family of Ca++ independent CAMs. Previous studies of NCAM cDNAs have revealed an
alternatively spliced set of small exons (12A, 12B, 12C, 12D) that encode a
region in the extracellular portion of the molecule known as the muscle
specific domain (MSD). The entire MSD region can be expressed in skeletal
muscle, heart, and skin; only exons 12A and 12D have been found in brain.
These studies, however, did not reveal which NCAM polypeptides contain
the MSD region or the immunohistochemical distribution of these NCAM
molecules.

To address these questions, we prepared antibodies against the

oligopeptides encoded by exons 12A and 12B and by exons 12C and 12D and
used these antibodies to study the forms of NCAM containing the MSD
region expressed during embryonic chicken heart development.

These

antibodies recognize certain forms of NCAM found in the heart but do not
recognize brain NCAM. In the heart, each of the splice variants of NCAM (ld,
sd, and ssd) that differ in their mode of attachment to the plasma membrane
or in the size of their cytoplasmic domain is expressed in a form containing
and in a form lacking the MSD region. No microheterogeneity is observed in

XIII

the size of NCAM molecules containing the MSD region, even at the level of
CNBr fragments, suggesting that exons 12A-D are expressed as a single unit.
We have identified six different isoforms of heart NCAM which exhibit
changing temporal and spatial patterns of expression during development:
the three forms of NCAM, ld, sd, and ssd, can also be expressed in a form
containing the MSD sequence.

Depending on the site and the stage of

development, the percentage of NCAM molecules containing the MSD
region can vary from nearly

a to

increases during development.

100 percent.

In general, this percentage

In immunohistochemical studies of hearts

from stage 18 embryos, forms of NCAM containing the MSD regIon
colocalized with Z-discs. No other adhesion molecules were found in this
distribution at this early stage of development.

Studies on isolated cells in

vitro demonstrate that the colocalization with Z discs of NCAM molecules
containing the MSD region does not depend on cell-cell contact and raise the
possibility that this form of NCAM is involved in cell-extracellular matrix
interactions.

The association of NCAM molecules containing the MSD

region with Z discs suggests that this form of NCAM is involved in early
myofibrillogenesis.

XlIII

INTRODUCTION

NCAM, The Neural Cell Adhesion Molecule

The cellular and molecular processes of development within an
organism involve series of biological changes. Initiation or progression of
each developmental event such as cell migration, proliferation, or tissue
differentiation is precisely programmed to be coordinated in time and space.
It has been demonstrated that cell adhesions are important contributors to the
estabishment of form and pattern during development (17, 74). In general,
adhesion occur by two ways, cell-cell interactions or cell-extracellular matrix
interactions. These interactions are based on specific adhesion molecules, cell
adhesion molecules (CAMs) and cell-substrate adhesion molecules (SAMs).
CAMs are membrane receptors that mediate cell-to-cell adhesion by their
interactions at the cell surface. CAMs are largely divided into two groups
accordirlg to their Ca++ -dependence: the Ca++ -dependent adhesion molecules
known as cadherins and the Ca++ -independent adhesion molecules including
the neural cell adhesion molecule (NCAM) (17, 32, 74). SAMs mediate cell-toextracellular matrix (ECM) adhesion by the interactions of extracellular matrix
proteins with their cell surface receptors (14, 18, 20, 24). At the functional
level, adhesion molecules specifically control cell behavior both directly and
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indirectly. That is, adhesion molecules directly mediate the cell migration
and maintain tissue borders at the surface of cells, and at the same time
adhesion

molecules

indirectly

affect the

fate

of

cells

through

the

transmembrane signal transduction mechanisms their binding initiates (11,
17, 33, 36, 65, 70).
Among the cell adhesion molecules, NCAM has been of particular
interest to us.

NCAM mediates cell-cell adhesion both by a homophilic

mechanism (31, 52, 61, 62), i.e., NCAM to NCAM, and by heterophilic
mechanisms involving the interaction of a heparin-binding domain in
NCAM with heparan sulfate proteoglycans (57) or the interaction of NCAM
with neurocan, a chondroitin sulfate proteoglycan (54). NCAM is expressed
in a number of cell types including neuron, skeletal muscle, heart, kidney,
liver, gizzard, ovary, skin, testis, and lymphocyte (2, 10, 65).

It is present

abundantly in various tissues from very early embryos through adults (2, 17).
It plays major morphoregulatory roles in guiding tissue formation and
differentiation (2, 17). NCAM is structural diverse (46). It contains a large
number of unusual polysialic acid (PSA) side chains that are important for its
adhesive function (1, 9, 17, 32).

Structural Diversity of the NCAM Polypeptide

NCAM was the first cell adhesion molecule to be identified. It is a cell
surface glycoprotein containing large amonts of polysialic acid (PSA). PSA is

2

composed of unIque a-2,8-linked oligo saccharides that are rare in other
molecules (9, 21, 60). One type of NCAM heterogeneity is due to differential
polysialylation. Polysialylation modulates NCAM adhesion (I, 31) and the
level of polysialylation of NCAM correlates with development of an
organism (13, 21, 31, 32).
Another type of heterogeneity IS found in the NCAM poypeptide.
NCAM belongs to the IgG superfamily, containing immunoglobulin (IgG)homologous domains.

The extracellular structure is well conserved in all

NCAM species: there are five IgG-domains and two fibronectin type III
homologous repeats (9, 32) (Figure 1). In contrast, the cytoplasmic portion of
NCAM exhibits a great deal of structural heterogeneity. One form of NCAM,
ssd (small surface domain), is covalently linked to the plasma membrane via
glycolipid glycosyl-phosphatidylinositol (GPI); two integral membrane forms,
ld (large domain) and sd (small domain), differ in the size of their cytoplasmic
domains (3, 27, 28, 46, 62). These various forms of NCAM are produced by
alternative mRNA splicing from a single gene.

Studies have shown that

forms of NCAM vary according to the tissue type. The ld form is a major
NCAM species in brain tissue, while sd or ssd are predominant in skeletal
muscle. It has been predicted that tissue-specific modes of alternative splicing
exist for NCAM synthesis.

However, the molecular mechanism through

which splicing occurs is still not known.
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Figure 1. Models of three major NCAM Splice Variants.
The structural diversity of NCAM largely divides into three groups as
illustrated. All three forms are similar in their extracellular structure: five
IgG homologous domains (hatched oval) at the N-terminus are followed by
two fibronectin-like repeats (0). Unique polysialic acid side chains (9) are
covalently bound to the IgG homologous domains. The NCAM splice
variants differ in their mode of cell membrane attachment or in the
truncation of transmembrane and/ or cytoplasmic region. While the ld (large
domain) form contains an entire sequence encoded by all 19 exons, the sd
(small domain) lacks the exon 18 (gray box)-encoded region, or the ssd (small
surface domain) is only GPI-linked (staggered line) to the cell membrane
(hatched box) with transmembrane and cytoplasmic regions exclusively
truncated (see Figure 3 for more details).
Figure source: Edelman & Crossin. 1991. "Cell adhesion molecules:
implications for a molecular histology". Annu. Rev. Biochem.
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NCAM Splice Variants with the MSD Region

In addition, two small inserts in the NCAM polypeptide have been
identified. They are spliced into two distinct locations in the extracellular
portion of NCAM by alternative mRNA splicing. One is the VASE (variable
alternatively spliced exon) insert that is present between the sequences
encoded by exons 7 and 8 and is found in both brain and heart (64, 66, 67, 79).
The other is the so-called muscle-specific domain or MSD region encoded by
four small exons (12A, 12B, 12C, 12D) that are found between exons 12 and 13
(51, 72) (Figure 2, 3).

This insert is expected to be localized between two

fibronectin homologous domains in the extracellular portion of NCAM.
Because no reagents that recognize MSD polypeptide have been prepared
previously, little was known of the distribution, structure, and function of

MSD polypeptides.
Molecular biology study based on RT-PCR (reverse transcriptase-based
polymerase chain reaction) has suggested that the MSD is expressed in a
variety of splice combinations of these four small exons (56). For example,
only exons 12A and 12D from this region are expressed in the brain (26, 55,
64), all four of these small exons are expressed in heart, skeletal muscle, and
skin (IS, 43, 51). While the sequence of these four small exons is highly
conserved between humans, rats, and mice, two of the four chicken exons
(12A and 12B) are very different in sequence from their mammalian
counterparts (51).
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Figure 2. Structure of the NCAM Gene and an Intact NCAM Polypeptide.
(A) The size and location of introns (0) and major exons (_) are
indicated in the map. (B) The predicted structure of an intact NCAM
polypeptide (B). The structure of ld (large cytoplasmic domain) species is
illustrated. ld is the largest splice variant of NCAM which is encoded by the
most of major 19 exons. The immunoglobulin homologous regions are
shown (loops I-V). Alternative mRNA splicing can generate the other two
major variants. The sd (small domain) transmembrane variant lacks the
exon 18 sequence. The GPI-linked ssd (small surface domain) variant
contains an extra sequence encoded by exon 15. kb = kilobase.
Figure source: Cunningham, B. A. 1988. liThe structure and function
of cell adhesion molecules". Advances in Cell BioI.
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Figure 3. Schematic model of forms of NCAM produced by alternative
mRNA splicing in the MSD and membrane attachment regions.
Exon numbers encoding the various regions within the molecule are
indicated. ld, sd, and ssd forms differ in their attachment to the membrane
through the expression of transmembrane and cytoplasmic exons 16, 17, 18,
and 19 or through the expression of exon 15 encoding a peptide that becomes
covalently linked to CPI. The MSD region comprised of exons 12A, 12B, 12C,
and 12D is expanded, the sequences of the peptides from this region used to
immunize rabbits are shown in single-letter code.
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In human skeletal muscle, the MSD comprises 37 amino acids and is
encoded by at least three small exons of 15, 48, 42 bp at the junction of exons
12 and 13 (15, 72). Similarly, chicken MSD is 31 amino acid sequence. This
heart insert is encoded by a set of four exons, 12 A, B, C, and D of 15, 33, 42,
and 3 bp, at the same genetic location (15, 51, 56, 64).
Interestingly, mRNA encoding the MSD region of NCAM has been
detected only in some tissues. The MSD exists in NCAM molecules produced
in skeletal muscle, heart, and skin NCAM, but not in brain, gizzard, or liver.
This suggests that the expression of MSD sequence is very tissue-specific (15,
26, 43, 75, 78).

Structural versus Functional Diversity of NCAM

NCAM is a multifunctional adhesion molecule which can bind to
more than one specific ligand. NCAM operates via both homophilic (31, 53,
61, 62) and heterophilic binding mechanisms.

That is, the NCAM binds to

NCAM on apposing cells (31) as well as to other ligands such as heparin or

heparan sulfate proteoglycan (57). Specific domains within NCAM mediating
various types of NCAM interactions have begun to be uncovered by
mutational analyses or by domain-targeted inhibition studies (53). However,
very little is known about the importance of small structural motifs, VASE
and MSD, that are present in NCAM. Functional studies on splice variants of
NCAM suggest that the expression of the VASE insert inhibits neurite
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outgrowth, while the MSD region has no effect on it (16). On the other hand,
recent experiments suggest that the MSD insert found in the 125 kD NCAM
played a role in myoblast fusion during myogenesis (49). These observations
strongly suggest that inclusion of a small peptide motif significantly affects
the NCAM function.

Structural features of the MSD include consecutive

proline residues as well as a-linked carbohydrate acceptor sites (75).
The mode of association of NCAM with the cell membrane may also
have functional consequences. A transfection study has shown that the GPIlinked ssd form of NCAM is targeted to the apical surface of polarized
epithelial cells differently than the transmembrane
demonstrate

that transmembrane

forms

of NCAM

form

(50).

Others

downregulate

the

secretion of a matrix metalloproteinase, gelatinase, while the GPI-linked form
(125 kD) does not have this effect (19).

Our studies have focused on the expressIon of the MSD insert in
NCAM species. We have carefully examined the structural and functional
alteration of NCAM in the presence of a MSD motif. We also have compared
the spatial or temporal distribution of NCAM species in heart tissue and
related their potential function to heart morphogenesis.

NCAM Function and Heart Development

There are many stages in early heart development when changes in the
expression or function of cell-cell adhesion molecules may mediate or stablize
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changes in morphology or may influence other developmental process. The
best-known example of NCAM-mediated differentiation in the heart occurs
during the formation of valves.
Initially, the primitive

heart (precardiac mesodermal

epthelium)

appears as paired primordia (6, 59). NCAM and N-cadherin are expressed on
almost all of these cells (7, 40). Some of these precardiac cells deadhere as they
downregulate

expreSSIon

of

these

adhesion

molecules,

mesenchymal

cells, and migrate into the basement membrane.

primitive heart primorida then fuse to form
consisting

of

myocardium,

an

Inner

and

respectively)

outer

epithelia

separated

by a

convert

into
The

one double-layered tube
(the

middle

endocardium
acellular

and

basement

membrane known as the cardiac jelly.
The transformation of the heart from a simple tube to a fourchambered

structure

containing

mesenchyme transformation.

valves

involves

a

second

epithelial-

That is, the ECT arIses from cells of the

endocardial endothelium that de-adhere, convert into mesenchymal cells,
and

migrate

into

the

cardiac

jelly

(the

epithelial-mesenchymal

transformation) (38, 41). NCAM is continuously expressed on all cells of the
myocardium

and endocardial endothelium;

in contrast,

N-cadherin

is

expressed only in the myocardium at this stage of heart development (40).
Concomitantly with their de-adhesion, migrating ECT cells down-regulate
their expression of NCAM (7, 45) as assayed immunohistochemically (7, 45,
71). Later in development, the growing cushion tissue pads fuse in a manner
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that subdivides the flow of blood through the heart into two channels.

It is

therefore likely that the regulation of NCAM expression or function plays a
major role in mediating this sequence of de-adhesion and adhesion that occur
during the epithelial-mesenchymal transformation and the fusion of cushion
tissue pads.
While cDNA sequence data have demonstrated the existence of NCAM
molecules containing the MSD region, the presence of these inserts in
particular NCAM polypeptides and their immunohistological distribution in
the tissue have not been examined. This was due to the absence of specific
antibody probe that can selectively identify the MSD peptide inserts found in
NCAM subspecies. This thesis, therefore, emphasizes two specific aims. The
first aim is to identify and characterize NCAM species containing the MSD at
the level of protein.

This requires production of an antibody specifically

directed against the MSD sequence.

The second aim is to study tissue

distribution and subcellular localization of NCAM containing the MSD. This
is to understand the significance and mechanism of MSD function among
NCAM variants.

As a research model, we have chosen chicken heart

development and focused on tissue differentiation in the myocardium in
particular.

We found that NCAM expression including species containing

the MSD undergoes dramatic changes while myofibrillogenesis occurs. The
present studies suggest the potential function of MSD-containing NCAM.
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MATERIALS AND METHODS

Reagents

Reagents were purchased from the following sources: Keyhole limpet
hemocyanin (KLH), Calbiochem (San Diego, CA); N-succinimidyl 3-(2-pyridyl
dithio) propionate (SPDP) and BCA protein assay kit, Pierce (Rockford, IL);
reagents for gel electrophoresis and Western blotting, Bio-Rad Laboratories
(Hercules, CA); leupeptin, Boehringer Mannheim Corp. (Indianapolis, IN);
neuraminidase

from

Streptococcus

sp.

(catalog number

151738), ICN

Biomedical Inc. (Costa Mesa, CA); DE 52, Whatman Lab Sales Inc. (Hillsboro,
OR); CNBr, Aldrich Chemical Co. Inc. (Milwaukee, WI).

All other reagents

were obtained from Sigma Chemical Co. (St. Louis, MO) .

Antibodies

Anti-NCAM:

NCAM from 14-day embryonic chicken brains, purified as

described below or as previously described (32), was used to immunize rabbits.
This antibody is frequently referred to as the pan NCAM antibody because it
recognizes all forms of NCAM.
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Anti-12AB and anti-12CD:

Two peptides that together comprIse the MSD

region in chicken NCAM (Prediger et al., 1988) were synthesized by the MUSC
Protein Sequence Facility. Oligopeptide 12AB contains the sequence encoded
byexons 12A and 12B (single letter code RIPHSPSAAAPTCLAE); oligopeptide
12CD

contains

the

sequence

encoded

by

exons

12C

and

12D

(TTQPLPASESTEPPKG) (Figure 3). Each peptide was synthesized with two
additional cysteine residues at its C-terminal.

In order to induce strong

immunogenicity, each oligopeptide was conjugated with KLH prior to
immunization.

First, Cys residues were reduced using 100 mM dithithreitol

(DTT) for 30 min, and the pep tides were desalted on G-25 Sephadex
equilibrated in 0.1 M sodium phosphate/ 0.1 M sodium chloride (NaCI), pH
7.5. KLH was desalted using this same buffer, then activated with SPDP at a
molar ratio of 1: 2,500 for 1 hour, then desalted again.

Finally, the reduced

oligopeptides were incubated with the activated KLH at a 500:1 molar ratio for
1 hour, then desalted.

These oligopeptide-KLH conjugates were dialyzed

against water, lyophilized, and resuspended in phosphate buffered saline
(PBS).

Subcutaneous inoculations into rabbits (50 J.Lg NCAM or 1 mg

oligopeptide-KLH conjugates per rabbit per injection) and IgG purification
from serum were performed by standard methods (71).
Monoclonal antibodies 4d (specific for the ld form of NCAM) and V2E9
and JG22 (each specific for the f31 integrin subunit) were obtained from the
Developmental Studies Hybridoma Bank.
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Monoclonal antibody NCD-2

(specific for N-cadherin) was a gift from Dr. Jack Lilien, Clemson University,
Monoclonal

Clemson, SC.

antibodies

against vinculin

and

a-actinin

(sarcomeric) were obtained from Sigma Chemical Co. [Product Numbers V9131 (clone hVIN-1) and A-7811 (clone EA-53) respectively].

Slot Blot

This simple assay allows the determination of the ability of an antibody
to interact with a native (non-denatured) antigen. The antigen is placed in a
plastic slot and transferred onto a nitrocellulose membrane by gravity or a
mild vacuum (Slot Blot kit, Bio-Rad). The membrane-bound antigen is then
detected by Western blotting. The membrane is blocked in tris buffered saline
(TBS) containing 3
presence of 1

%

%

gelatin, incubated with a primary antibody in the

gelatin,

incubated with

a secondary antibody-alkaline

phosphatase conjugate. Color development is performed in carbonate buffer,
pH 9.8, using bromochloroindoyl phophate (BCIP) and nitroblue tetrazolium
(NBT) substrates. The resulting color on a membrane is scanned using an
Apple Macintosh computer and Adobe Photoshop software.

The image

information is then converted to numeric data using an Image Anaysis
Program 1.4.

ELISA (Enzyme-Linked Immunoabsorbent Assay)
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The sensitivity of this assay allows us an accurate estimation of the
96-\vell

specific interaction occurring between antibody and antigen.
microtiter plates are coated with

various

soluble

antigens

for

1 hr.

Nonspecific protein binding sites are blolcked with 3 0/0 bovine serum
albumin (BSA) in phosphate buffered saline (PBS) for 2 hr.

The primary

antibody and then the secondary antibody, a HRP (horseradish peroxidase)conjugate, are applied for 1 hr each in PBS containing 1 % BSA.
reaction

performed

IS

uSIng

ethylbenzoothiazoline-6-sulfonic
hydrogen peroxide (H 20

2 ),

substrates,

acid)

2,

diammonium

The color

2' -Azinobis
salt

(3-

(ABTS)

and

and is quantitated by measuring the optical density

(OD) at 414 nm using a plate reader.

Western Blot

Samples were resolved by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) under

reducing conditions

on

minigels

containing

6 0/0

acrylamide except in the experiment on cyanogen bromide (CNBr) fragments
of NCAM in which 12
were

used

nitrocellulose

to

%

enhance

acrylamide was used and non-reducing conditions
antigenicity.

Proteins

using a semi-dry transfer method

Electrophoretic Transfer Cell, Bio-Rad).

were

transblotted

(Trans-Blot

to

Semi-Dry

The nitrocellulose was blocked,

incubated with primary antibodies, incubated with secondary antibodies (goat
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anti-rabbit or anti-mouse IgGs conjugated to alkaline phosphatase), and color
developed using BCIP and NBT as described as above (Reagents, Bio-Rad).

Preparation of Membranes! NP40 Extraction! Neuraminidase Treatment!
PIPLC Digestion

Purified membranes were prepared from 14-day embryonic chicken
brains and 14-day embryonic and adult chicken hearts. Brains in cold PBS
containing protease inhibitors (N-ethylmaleimide, 10 mM; benzamidine, 5
mM; leupeptin, 50 f.lg/ml; aprotinin, 2 J..lg/ml; phenylmethylsulfonylfluoride
(PMSF), 2mM; pepstatin A, 5 f.lg/ml) were homogenized using a Braun-Sonic
2000 U ultrasonic generator. Homogenates were overlayed on PBS containing
42

%

sucrose, then ultracentrifuged at 100,000 g for 30 min at 4

membrane fraction which appeared above the 42

%

0

C.

The

sucrose was harvested,

washed by dilution with cold PBS, and collected by centrifugation at 8 K rpm
for 20 min in a JA10 rotor in a Beckman J2-HS High Speed Centrifuge. For
heart membrane preparation, tissue was sonicated in ice-cold hypotonic
buffer (200 mM sucrose/ 5 mM sodium phosphate, pH 7.5/ 1 mM (ethylenedioxy) diethylenedinitro tetraacetic acid, EGTA) in the presence of protease
inhibitors.

Low-speed centrifugation, 300 g for 10 min,

membranes from nuclei and large debris.

separated the

Membranes in the supernatant

were then collected by ultracentrifugation at 100,000 g for 30 min.
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Preparation of Cell Membranes

14D Chick Brains

14D Chick Hearts

mb is hom!geniZed
in PBS / protease inhibitors

mb is homogenized
in hypotonic BF / protease inhibitors

I

I

macromolecular debris is removed
by ultracentrifugation
through a 42 % sucrose cushion
(lOO,OOOg, 30 min, 4° C)

macromolecular debris is pelleted, discarded
(low speed centrifugation, 300g, 10 min, 4 oC)

I

mb is pelleted
(ultracentrifugation, 100,000g, 30 min, 40 C)

mb in PBS }s pelleted
(centrifugation, 8000 rpm, 20 min, 40 C)

ECM contaminants are washed with 0.1 M Tris base,
mb is neutralized with 0.2 M phosphate, pH 6.3.

Figure 4. Preparation of Cell Membranes from Embryonic Chicken Tissue.
Embryonic day 14 chicken tissues, brain or heart, are isolated and
homogenized. Cell membrane is fractionated from cytoplasmic contaminants
by ultracentrifugation (see details in the Materials and Method section).
Abbreviations: mb (membrane), BF (buffer), PBS (phosphate buffered saline),
ECM (extracellular matrix)

17

Crude membranes

were prepared from

4-day, 7-day, and 10-day

embryonic chicken hearts and 5-day embryonic chicken ventricles
cushion tissue pads.

and

Tissue in PBS was homogenized in the presence of

protease inhibitors, then washed with PBS and harvested by two rounds of
centrifugation (14,000 rpm, 3 min) in a microfuge (Figure 4).
To prepare nonidet P-40 (NP40) extracts for Western blotting and
peanut lectin chromatrography, membranes were pelleted in a microfuge
(14,000 rpm, 3 min), resuspended in 10 volumes of 0.5

%

NP40/ PBS, and the

extracts clarified in the microfuge (14,000 rpm,S min). The protein content of
NP40 extracts was quantitated using the BCA assay.
To

neuraminidase

treat

membranes,

pelleted

membranes

were

resuspended in 3 volumes of PBS containing 0.3 U / ml of neuraminidase,
incubated for 1 hour at 37° C, then washed with PBS and harvested by
centrifugation.

To neuraminidase treat NP40 extracts, neuraminidase was

added to NP40 extracts to a final 0.3 U / ml and incubated 1 hour, 37° C.
To

phosphotidylinositol-specific

phospholipase

C

(PIPLC)

digest

membranes, pelletted membranes were resuspended in 3 volumes of PBS
containing 0.02 U / ml of PIPLC (from Bacillus cereus, Sigma catalog number P
8804), incubated for 30 min at 37° C, and the PIPLC-released molecules in the
supernatant harvested by centrifugation in a microfuge (14,000 rpm, 3 min).
The residual membrane pellet was NP40 extracted as described above.
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Immunoprecipitation of NCAM Molecules Containing the MSD Region

Purified membranes from 14-day embryonic chicken hearts (50 JlI
packed volume) were resuspended in 0.5 ml PBS containing 1mg/ml anti12AB or anti-12CD immunoglobulin (IgG) and incubated for 1 hour at 4° C
with agitation.

Membranes were washed with PBS and harvested by two

rounds of centrifugaton in a microfuge (14,000 rpm, 3 min). The membranes
were extracted with NP40 as described above and antigen-antibody complexes
were collected by incubation with 50 Jll of Protein A-Sepharose for 1 hour at
4° C. The beads were then washed several times with 0.5

NP40/ PBS.

%

Bound NCAM was eluted by boiling the beads in SDS-PAGE sample buffer
and Western blotted using the pan NCAM antibody as the primary antibody
for detection. This procedure allowed immunoprecipitation experiments to
be performed

using

anti-12AB

and

anti-12CD.

Immunoprecipitation

experiments performed with these antibodies in which the antibodies were
added to proteins which had already been NP40 extracted gave uniformly
negative results.

Peanut Lectin Chromatography

1.5 ml of NP40 extract from

purified membranes

from

14-day

embryonic chicken hearts was incubated with 50 Jll of peanut lectin-agarose
(Sigma catalog number L 2507) for 1 hour at 4 ° C with agitation.
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The beads

were then washed several times with 0.5
were eluted with 0.5 ml of 0.5

%

%

NP40/ PBS and bound proteins

NP40/ PBS/ 0.1 M galactose.

Purification of NCAM! CNBr Digestion

Packed brain or heart membranes were resuspended in 10 volumes of
0.1 M Tris base to elute weakly attached proteins. Membranes were collected
by ultracentrifugation and extracted in 10 volumes of 0.5

%

NP40/ 0.2 M

sodium phosphate, pH 6.3 containing protease inhibitors. Extracts were
clarified by ultracentrifugation and applied to DE 52 equilibriated in 0.5

%

NP-

40/ 0.2 M sodium phosphate, pH 6.3 (10 ml of extract per ml of beads). The
column was washed with 0.2 M sodium phosphate, pH 6.3 until no NP40
could be detected in the eluate.

Contaminants were then eluted with 1 M

NaCI/ 20 mM sodium phosphate, pH 6.5. The column was then washed with
25 mM octylthioglucopyranoside (OTG)/ 20 mM sodium phosphate, pH 6.5.
Finally, NCAM was eluted from the DES2 using 0.55 M NaCI/ 25 mM OTG/
20 mM sodium phosphate, pH 6.5. The eluate was dialyzed versus water and
lyophilized.

NCAM was further purified by HPLC gel filtration on a

TosoHaas G4000SW column equilibrated with 25 mM OTG/20 mM sodium
phosphate, pH 6.S (Figure 5). This procedure yielded brain NCAM that was
essentially 100
about 30

%

%

pure as evaluated by SDS-PAGE and heart NCAM that was

pure.
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Purification of NCAM

Cell mb is prepared

l
Mb Proteins Extracted by 0.5
l

% NP40/ 0.2 M phosphate, pH 6.5

DE 52 Ion Exchanger
Extract is poured into the column,
NP40 is washed out,
Contaminants are washed with 1 M NaCI,
Column is re-equilibrated with 25 mM OTG,
NCAM is finally eluted with 0.55 M NaCI/25 mM OTG.

~

Eluate is dialyzed & lyophilized

~
HPLC Gel Filtration G4000SW

Figure 5. Purification of NCAM Molecules from Tissue Extract.
Proteins are extracted from the cell membrane fraction by NP40 (see
Figure 4). Cell membrane extract is subjected to a DEAE anion exchange
chromatography where the NCAM is eluted by a high salt buffer containing a
detergent, GTG.
NCAM is further purified by high pressure liquid
chromatography using a G4000SW column. The purity of NCAM molecules
is analyzed by gel electrophoresis and western blotting. Abbreviations: mb
(membrane), NP40 (nonidet P-40), OTG (otyl thioglucopyranoside), HPLC
(high pressue liquid chromatography).
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Purified NCAM was dialyzed versus water, adjusted to a final 70 0/0
formic acid, and treated with a large excess of CNBr under N 2 overnight, then
dried in a Speed-Vac. This material was then dissolved in a small volume of
25 mM OTG / PBS and neuraminidase treated as described above.

Imm unohistochemistry

Hamburger-Hamilton (25) stage 18 chicken embryos were briefly rinsed
in PBS and placed in plastic molds with Tissue-Tek compound media (ICN).
Samples were quick frozen using liquid nitrogen.

Five micron frozen

sections were cut and mounted on poly-L-Iysine-coated slide glasses. After
rinsing off the embedding medium with distilled water and PBS, the sections
were incubated at room temperature with 10
30 minutes to block non-specific binding.

%

normal goat serum /PBS for

Sections were incubated with

primary antibodies (25 J.Lg/ml for rabbit antibodies, 10 J.Lg/ml for monoclonal
antibodies except for anti-vinculin and anti-u-actinin which were used at
1:400 and 1:800 dilutions respectively as per the vendor's instructions) in 1 0/0
BSA/PBS in a humid chamber at 4 °C for 4-16 hours, then rinsed with 1 0/0
BSA/PBS.

Appropriate fluorescein conjugated secondary antibodies [10

J.Lg/ml of goat anti-rabbit IgG or goat anti-mouse IgG (Organon Teknika Corp.,
Durham/ NC) in 1

%

BSA)PBSJ were applied for one
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hOUT""

foJJowed by rjnsjng

and mounting in 90% glycerol, 0.2 M n-propyl gallate (22). Stained sections
were examined by epifluorescent illumination using a Zeiss Axioscope.
Two experiments were performed to verify that the only molecules
recognized by anti-12CD are NCAM molecules
sequence used as immunogen.

containing the peptide

In one, the diluted antibody (25 Jlg/ml) was

pre-absorbed by mixing with 1.25 Jlg/ml of the immunogenic peptide for 30
minutes at room temperature, followed by clarification at 13,000 g.

In the

second, tissue sections were preincubated with the pan NCAM antibody (25
Jlg/ml) for 4 hours prior to addition of anti-12CD (25 f.lg/ml). Both treatments
completely blocked anti-12CD staining.
To examine the distribution of anti-12CD staining in cultured cells,
cells were released from stage 18 hearts as described by Krug et al. (38) and
depleted of fibroblasts as described by Lau (39).

This method selectively

removes the fibroblastic cells which grow rapidly in a monolayer culture than
myocytes.

Ventricle portions of hearts are trypsinized to disperse and the cell

suspension is allowed to settle for 2 hours in a culture dish.

Because

fibroblasts adhere to the dish ahead within this period, the media mainly
composed of myocytes is then transferred to a new culture plate.

The

enriched cardiomyocytes were plated on slides coated using a 20 Jlg/ml
solution of fibronectin (New York Blood Center, New York, NY) and
incubated for 3-7 days in the 'complete M199 medium' of Krug et al. (38).
0

Cells were fixed with cold methanol (10 min, -20 C), then rinsed briefly with
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50

%

methanol/50

%

PBS followed by a PBS rinse.

Cells were stained as

described above and examined by confocal microscopy.

Confocal Microscopy

As described above, lO-J.!m frozen sections were prepared and stained
with anti-12CD as the primary antibody and fluorescein isothiocyanate (FITC)conjugated goat anti-rabbit IgG as the secondary antibody. The sections were
then double stained by further incubation with either monoclonal anti-aactinin (sarcomeric) followed by tetramethylrhodamine isomer R (TRITC)conjugated goat anti-mouse IgG or the pan NCAM antibody followed by
TRITC-conjugated goat anti-rabbit IgG. Stained sections were examined by
confocal microscopy using a Bio-Rad MRC-IOOO equipped with a Zeiss
Axioscope.

The confocal iris was set at the smallest value to obtain the

thinnest possible optical sections « 0.25 J.!m).
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RESULTS

Antibodies Specific to the MSD Region of NCAM

The whole NCAM gene is composed of 19 major exons. According to
Nothern blot and cDNA sequence data, a subset of NCAM contains a peptide
sequence that is encoded by four small alternatively spliced exons, 12A, B, C,
and D (Figure 2). The small four exons are located between exons 12 and 13 of
the NCAM gene. This portion of the molecule was originally (15) named the
muscle specific domain (MSD); this nomenclature will be used here.

The

MSD found in the chicken heart consists of 31 amino acid. The localization of
MSD is predicted to be between two fibronectin homologous repeats in the
extracellular region of NCAM protein.

The predicted localization and the

deduced amino acid sequence of this region of NCAM are shown in Figure 2.
Since our initial goal was to identify the subset of heart NCAM that
contains the MSD insert in its protein structure, it was necessary to produce
an antibody specific to this MSD sequence. Using synthetic oligopeptides, two
polyclonal antibodies were prepared against the MSD region of NCAM; one
(anti-12AB) is against the polypeptide sequence encoded by exons 12A and
12B, the second (anti-12CD) against the polypeptide encoded byexons 12C and
12D (see Methods for details of antibody production).
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First, we tested the

Sequence Specificities of the Anti-MSD Antibodies

Anti-12CD

Anti-12AB
...-
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0---peptide
12AB

peptide
12AB

peptide
12CD

peptide
12CD

Figure 6. Specificity of Anti-MSD Antibodies against MSD Sequences.
MSD oligopeptides were challenged with anti-MSD antibodies in an
ELISA. A 96-well microtiter plate was coated with 20 ng of 12AB or 12CD
oligopeptide, incubated with the anti-MSD (anti-12AB or anti-12CD) antibody,
then incubated with the secondary antibody-horseradish peroxidase
conjugates. The subsequent color reaction measured at absorbance 414 nm is
indicated at the y-axis with arbituary numbers. The results show that within
the MSD sequence each anti-MSD recognizes an independent sequences; anti12AB is specific to the 12AB sequence, whereas anti-12CD is specific to the
12CD sequence.
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Figure 7. Anti-MSD Recognizes NCAM from Heart Tissue
but Not from Brain.
The ability of anti-MSD to recognize intact NCAM molecules was
examined by slot blotting. Matching slots in the left and right row contain
equal amounts of purified brain and heart NCAM, respectively. From the
top, slots contain 10 ng (top), 50 ng (middle), or 250 ng (bottom) of purified
NCAM. The antigen immobilized in the slot was challenged with various
anti-NCAM antibodies, then the result is shown by secondary antibodymediated alkaline phosphatase color reaction. NCAM isolated either from
brain or heart tissue is recognized by a pan anti-NCAM antibody. The anti12AB or anti-12CD exclusively recognizes the NCAM species that are present
in heart tissue.
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NCAM
205 -

12AB

12CD

155 kD
145kD
125 kD
120kD

116 -

97-

Br Ht

: Detection

--- 155 kD
..- 125 kD

Br Ht

Br Ht

Figure 8. Specificity of Antibodies against the MSD Region of NCAM.
As described in the Methods, NP40 extracts of 14-day embryonic
chicken heart and brain membranes were neuraminidase treated, then
Western blotted using antibodies prepared against the indicated antigens as
the primary antibodies for detection. Brain or heart extract is loaded to
contain equal amount of NCAM to each lane; lanes containing heart extract
(Ht) were loaded with 5 ~g of protein for detection with the pan NCAM
antibody and 15 ~g of protein for detection with anti-12AB or anti-12CD, also,
lanes containing brain extract (Br) were loaded with 1 ~g of protein for
detection with the pan NCAM antibody and 3 ~g for detection with anti-12AB
or anti-12CD. This 5:1 ratio of heart extract to brain extract results in similar
levels of total NCAM detected with the pan NCAM antibody. The four forms
of heart NCAM recognized by the pan NCAM antibody (ISS, 145, 125, and 120
kD) and the two forms of heart NCAM recognized by anti-12AB and anti12CD (155 and 125 kD) are indicated. An extra band seen in the brain extract
detected by anti-NCAM is the proteolytic fragment of NCAM produced
during tissue preparation. The migration of standard proteins is indicated by
their Mr x 10-3 .
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Figure 9. Forms of NCAM in 7-day Embryonic Heart Tissue.
As described in the Methods, NP40 extracts of membranes were
neuraminidase treated, then Western blotted using antibodies specific for the
indicated antigens as the primary antibodies for detection (180 kD indicates
the use of monoclonal antibody 4d specific for the ld form of NCAM). Lanes
containing 7-day embryonic heart extract (Ht) were loaded with 5 Ilg of
protein for detection with the pan NCAM antibody or 4d and with 15 Jlg of
protein for detection with anti-12AB or anti-12CD. The lane containing 14day embryonic brain extract (Br) was loaded with 1 Ilg of protein. The 185 and
180 kD forms of heart NCAM recognized by a 4d (anti-180) antibody are
indicated.
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molecular weight of about 180 kD and had previously been demonstrated
conclusively only in neural tissues.
Extract of 7-day embryonic hearts was analyzed for NCAM expressIon
(Figure 9). Including the three basic forms of heart NCAM (the ld, sd, and ssd)
that have been previously predicted by the molecular biology data, we detect
total six different structural variants of NCAM from the day 7 embryonic
heart. That is, the 185 and 180 kD forms are newly detected in addition to the
four species (155, 145, 125, and 120 kD) observed in 14-day heart extracts
(compare to Figure 8). The 185 kD, 145 kD, and 125 kD species all contain the
MSD region which is detected by anti-12AB and anti-12CD (Figure 9).
To determine whether the 185 and 180 kD forms of NCAM observed in
7-day embryonic heart are authentic ld NCAM, extracts were Western blotted
using monoclonal antibody 4d specific for this form of NCAM (76) (Figure 9).
Both the 185 and 180 kD forms of heart NCAM, as well as a form of brain
NCAM of similar molecular mass (known as the 180 kD), were recognized by
this anti-180 antibody. These results indicate that two forms of ld NCAM (185
and 180 kD) are present in heart extracts, and that one (185 kD) of those ld
forms also contains the MSD region.

Transmembrane' versus GPI-linked Forms of NCAM

To determine which of the forms of NCAM we observe are GPI-linked
to the plasma membrane, membranes from 14-day embryonic heart tissue
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Figure 10. Transmembrane and GPI-linked Forms of NCAM.
As described in the Methods, 14-dayembryonic heart membranes were
neuraminidase treated, treated with PIPLC to release GPI-linked proteins, and
the residual membranes were extracted with NP40. NP40 extracts (5 f.lg for
detection with the pan NCAM antibody; 15 f.lg for detection with anti-12CD)
and PIPLC-released material (from equivalent amounts of membranes as the
NP40 extracts) were Western blotted using antibodies prepared against the
indicated antigens as the primary antigens for detection. The four forms
(recognized by the pan NCAM antibody) of heart NCAM in NP40 extracts
(ISS, 145, 125, and 120 kD) and the two PIPLC-releasable forms of heart NCAM
(125 and 120 kD) are indicated.
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NCAM Splice Variants in Brain or Heart Tissue

mode ofmb
attachment
Id

sd
ssd

Heart

Brain

180kD

185 kD (MSD+, a-linked Sugar+ ?)
180kD

140kD

155kD (MSD+, a-linked Sugar+)
145kD

120kD

125kD (MSD+, a-linked Sugar+)
120kD

Table 1. Comparison of the Forms of NCAM in Brain and Heart Tissues.
NCAM consists of three structural forms defined by their modes of
membrane attachment. In heart, these ld, sd, or ssd forms are expressed with
or without the MSD sequence, whereas no MSD is expressed in brain NCAM.
A notable feature of the MSD is that it contains serine and threonine
sequences which are acceptor sites for O-linked oligosaccharides as
demonstrated by peanut lectin binding specificity (Figure 13). We assume the
185 kD form also binds to the peanut lectin as the other MSD containing
NCAM species (145 kD and 125 kD) do.
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were treated with PIPLC to release the CPI-linked forms. NP-40 extracts of the
residual membranes (Figure 10, A) or the PIPLC-released material (Figure 10,
B) were then Western blotted with either anti-NCAM or anti-12CD. Only the
125 and 120 kD forms of NCAM were released by PIPLC, and of these, only the
125 kD form was recognized byanti-12CD. As in Figure 8, the ISS, 145, 125,
and 120 kD forms of NCAM were present in the residual membranes, of
which only the 155 and 125 kD forms were recognized byanti-12CD. Thus, it
appears that the 185 and 180 kD forms of NCAM are ld, the 155 and 145 kD
forms are sd, and the 125 and 120 kD forms are ssd. In each pair, there is a
higher molecular weight species containing the MSD region and a lower
molecular weight species lacking the MSD region (summarized in Table 1).

The MSD Region Does Not Show Heterogeneity In Molecular Weight

PCR amplification studies of rat heart cDNAs suggested that alternative
splicing occurs among exons 12A-D which should lead to multiple forms of
NCAM with MSD regions of different sizes (Reyes et al., 1991). In contrast,
our results show no evidence for size heterogeneity in the MSD regions of ld,
sd, or ssd NCAM from either 7-dayor 14-day embryonic hearts (Figures 8, 9,
and 10). To evaluate whether we do not observe size heterogeneity because
the differences in the sizes of the variants are too small compared to the size
of the intact NCAM molecule, CNBr fragments of heart NCAM were
prepared and Western blotted with anti-NCAM, anti-12AB, and anti-12CD
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Figure 11. MSD region in CNBr digests of NCAM.
As described in the Methods, NCAM was purified from 14-day
embryonic brain and heart membranes, digested with CNBr, neuraminidase
treated, and Western blotted using antibodies prepared against the indicated
antigens as the primary antibodies for detection. Lanes containing brain
NCAM CNBr fragments (Br) were loaded with 10 Jlg of protein for detection
with the pan NCAM antibody and 30 Jlg of protein for detection with anti12AB or anti-12CD; lanes containing heart NCAM CNBr fragments (Ht) were
loaded with 30 Jlg of protein for detection with the pan NCAM antibody and
90 Jlg of protein for detection with anti-12AB or anti-12CD. This ratio of brain
and heart NCAM CNBr fragments was chosen to provide similar levels of
signal using the pan NCAM antibody for detection. The migration of
standard proteins is indicated by their Mr x 10-3 •
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(Figure 11). As expected from the localization of the MSD regIon within
NCAM (Dickson et al., 1987), anti-12AB and anti-12CD recognized a single
CNBr fragment of about 45 kO. No size heterogeneity in the MSD region was
seen even in these smalle.r CNBr digests. In control experiments, no CNBr
fragments of brain NCAM were recognized by either anti-12AB or anti-12CD,
even though the profiles of CNBr fragments of brain and heart NCAM
recognized by anti-NCAM were similar.

These results indicate that, at the

protein level, only one form of the MSD region can be detected in our
extracts, presumably that encoded by mRNAs containing the transcripts from
all of exons 12A, 12B, 12C, and 120.

Polysialic Acid on NCAM Inhibits
the Anti-MSD Accessibility to the Molecule

NCAM molecules bear unIque, maSSIve polysialic acid-containing
oligosaccharide(s) in a close proximity to the MSO region (9) (Figure 1). To
determine whether this structure interferes with the ability of anti-MSD
region antibodies to bind to the molecule, the ability of anti-12AB and anti12CD to recognize NCAM molecules

before and after neuraminidase

treatment was compared (Figure 12).

Whereas polysialic acid does not

interfere with the ability of anti-NCAM to recognize NCAM, anti-12AB and
anti-12CD do not recognize NCAM in Western blots (Figure 12, A) or by
immunoprecipitation (Figure 12, B) unless the polysialic acid is first removed
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Figure 12. Effect of Polysialic Acid on the Recognition of NCAM by Anti12AB and Anti-12CD.
A) Western blots. As described in the Methods, NP40 extracts of 14-day
embryonic heart membranes (15 ~g aliquots) either without (-) or with (+)
neuraminidase treatment were Western blotted using antibodies against the
indicated antigens as the primary antibodies for detection.
B)
Immunoprecipitation. As described in the Methods, NCAM from 14-day
embryonic heart plasma membranes, either without (-) or with (+)
neuraminidase treatment, was immunoprecipitated using anti-12CD IgG.
This material was Western blotted using the pan NCAM antibody as the
primary antibody for detection.
Similar results were obtained in
immunoprecipitation experiments using anti-12AB IgG (data not shown).
The heavy band. near the bottom of both lanes represents IgG heavy chain.
The migration of the 155 and 125 kD forms of NCAM containing the MSD
region is shown in both A and B.
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from the molecule. In contrast to the Western blot, anti-12CD does recognize
NCAM

equally

well

before

and

after

neuraminidase

treatment

In

immunohistochemical assays (Figure 16, 17, 18, 19, 20, and 22).

Forms of NCAM Containing the MSD Also Bind to Peanut Lectin

NCAM from a skeletal muscle cell line

consists of a 155 kD

transmembrane form that contains the MSD region and binds to peanut
lectin as well as a 125 kD GPI-linked form that does not contain the MSD
region and does not bind to peanut lectin (75). In order to characterize the
peanut lectin binding of heart NCAM, NP40 extracts of plasma membranes
from 14-day embryonic heart tissue were fractionated on immobilized peanut
lectin; the forms of NCAM in the total and eluate were then detected by
Western blotting with anti-NCAM, anti-12AB and 12CD (Figure 13). NCAM
molecules bind to peanut lectin only after neuraminidase treatment; even
then, only the two polypeptides (155 and 125 kD) recognized byanti-12AB and
anti-12CD bind to peanut lectin.

These results are consistent with the facts

that peanut-lectin binding oligosaccharides are believed to be O-linked and
that the MSD region contains two putative acceptor sites composed of Ser or
Thr residues for O-glycosylation.

Developmental Changes in the Expression of NCAM Splice Variants
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Figure 13. Binding of NCAM to Immobilized Peanut Lectin.
As described in the Methods, NP40 extracts of 14-day embryonic heart
membranes, either untreated (-) or treated (+) with neuraminindase, were
incubated with peanut lectin-agarose. Aliquots of the total extract (T) and the
0.1 M galactose eluate (E) were Western blotted using antibodies against the
indicated antigens as ,the primary antibodies for detection. Lanes containing
total extract were loaded with 5 Ilg of protein for detection with the pan
NCAM antibody and with 15 Ilg of protein for detection with anti-12AB or .
anti-12CD; lanes containing the galactose eluate were loaded with the
material purified from 20 Ilg of extract for detection with the pan NCAM
antibody and with the material purified from 60 }.lg of extract for detection
with anti-12AB or anti-12CD. The migration of the 155 and 125 kD forms of
NCAM that are specifically precipitated by immobilized peanut lectin and are
specifically recognized by anti-MSD region antibodies are indicated.
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The temporal expressIon pattern of NCAM specIes was examined
during the course of heart development.

The forms of NCAM present in

extracts from 4-day, 7-day, 10-day, and 14-day embryonic heart tissue and adult
heart tissue were compared by Western blotting (Figure 14). Dramatic shifts
were observed in the expression of ld, sd, and ssd NCAM as well as in the
proportions of each of these forms containing the MSD region. ld NCAM was
present at 4 days, peaked at 7 days, was still present at 10 days, but absent
thereafter. This observation supports our idea that the ld NCAM is actually
present in the heart (Figure 9) and not in the innervation of the heart,
because a different time course would have been expected for a molecule
associated with the innervation of the heart (peaking later and more
persistent) (77). The sd form of NCAM is expressed in a similar time course
as ld, while the ssd is expressed later in development and is essentially the
only form observed in adult tissue.
The ratio of MSD positive to MSD negative forms of NCAM varIes
during development.

For ld, sd, and ssd NCAM the percentage of the

molecules containing the MSD region always increases during development
(Figure 14). For example, in 7-day tissue the MSD-positive 185 and 155 kD
forms of ld and sd NCAM are present in similar concentrations to the MSDnegative 180 and 145 kD forms of ld and sd. By 10 days, these MSD-positive
forms are clearly present at higher concentrations than the corresponding
MSD-negative forms.

Similarly, the 120 kD MSD-negative form of ssd
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Figure 14. Forms of NCAM Present in the Developing Heart.
As described in the Methods, 5 ~g aliquots of NP40 extracts of
membranes from 4-day (4), 7-day (7), 10-day (10), and 14-day (14) embryonic
heart tissue, and from adult (A) heart tissue were neuraminidase treated,
then Western blotted using the pan NCAM antibody as the primary antibody
for detection. The migrations of the 185, 180,,155, 145, 125, and 120 kD forms
of NCAM are indicated; those containing the MSD region (185, 155, and 125
kD) are in bold. The identity of these forms of NCAM was confirmed in
parallel experiments using anti-12AB and anti-12CD for detection (data not
shown). The migration of standard proteins is indicated by their Mr x 10-3 •
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Table 2. Developmental Changes in NCAM Species.
Chicken hearts are isolated from the different stages of development and extracted with NP40. When
similar amounts of tissue extract are loaded to the gel, we observe that the ratios of NCAM species changes
dramatically according to heart development (Figure 14). Whereas the the membrane bound forms of NCAM
(ld. sd) are abundantly expressed at earlier stages, the PIPLC-linked forms (ssd) are dominant at later stages. In
adult, most NCAM are expressed as the PIPLC-releasable form. At any time of development, the MSD
containing NCAM subspecies compose a bigger population than the ones lacking it. Also, the percentage of
the MSD-positive NCAM increases as development proceeds.
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NCAM is present in 7-day tissue but below detection thereafter, while the 125
kD MSD-positive form of ssd NCAM continues at high concentration
throughout development (summarized in Table 2).

Spatial Variation in the Expression of NCAM Species

In order to understand the role of NCAM speCIes during heart
morphogenesis, we have carefully examined the tissue distribution and
subcellular localization of various NCAM forms.

Spatial variations in the

expression of forms of NCAM are readily detected in tissue extract prepared
from different compartments

of heart.

Ventricular

tissue (primarily

myocardium) from 5-dayembryos contains a similar set of forms of NCAM
(Figure 15) to that observed in the 4-day or 7-day heart (Figure 14). In contrast,
atrioventricular cushion tissue from 5-day embryos contains primarily one
form of NCAM, the MSD-negative form of sd. It contains much less ld, ssd,
or even the MSD-positive form of sd NCAM than does the ventricular extract
from the same stage embryos. Moreover, the small amount of MSD-positive
sd present may be due to myocardial contamination of the cushion tissue
given that cultured endocardial or mesenchymal cells contain only one form
of NCAM, MSD-negative sd (Mironov, V., R. R. Markwald, and S. Hoffman,
unpublished observations). Thus, the percentage of MSD-positive NCAM in
heart tissue can vary from almost

a to

development and region of the heart.
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Figure 15. Endocardial Cushion Tissue is Deficient in GPI-linked and MSD
Region-containing Forms of NCAM.
Ventricles (V) and cushion tissue (CT) pads were dissected from fiveday chicken embryos. As described in the Methods,S J.1g aliquots of NP40
extracts of membranes were neuraminidase treated, then Western blotted
using the pan NCAM antibody as the primary antibody for detection. Small
arrows on the left indicate the forms of NCAM (ISS, 125, and 120 kD) present
at relatively high levels in the ventricle and low levels in cushion tissue; the
large arrow on the right indicates the form of N-CAM (145 kD) present at
relatively high levels in both samples.
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Figure 16. Anti-12CD immunostaining of the Stage 18 Chicken Heart.
Anti-12CD immunostaining was detected in the myocardium (M),
whereas little staining was revealed in either endocardium (E) or in cushion
mesenchyme (CM). Scale bar = 100 J..lm.
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In order to determine the distribution at the immunohistochemical
level of NCAM molecules containing the MSD region, sections of stage 18
embryonic heart tissue were stained using anti-12CD (Figure 16). Since anti12AB was not useful in immunohistochemical studies, detection of the MSD
in tissues was mainly dependent on using anti-12CD. As predicted from the
results of Figure 14, the myocardium was stained with anti-12CD, while little
or no staining was seen in the endocardium or endocardial cushion tissue.
When the myocardial portion of these sections was observed at high
magnification, a striking subcellular distribution of NCAM molecules
containing the MSD region was observed; staining with anti-12CD appeared
to coincide with the position of Z discs (Figure 17). This staining was specific;
no staining was observed if the antibody was pre-incubated with the peptide
used to produce anti-12CD (Figure 17, b) and no staining was observed with
non-immune IgG (Figure 17, f). Although anti-NCAM antibodies did stain
the surface of myocardial cells, they did not highlight Z discs (Figure 17, c).
Other adhesion molecules, N-cadherin and

Bl

integrin, have previously

been shown to be associated with Z discs later in development (29, 37, 68). We
examined the expression of these proteins in stage 18 myocardium; while
both molecules were present, neither N-cadherin (Figure 17, d) nor

Bl

integrin (Figure 17, e) colocalized with Z discs. Therefore, at this early stage in
development, NCAM molecules containing the MSD region appear to
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Figure 17. Comparative Immunostaining of Different Adhesion Molecules in
the Stage 18 Chicken Heart Myocardium.
a) High magnification photomicrograph depicts a striking subcellular
distribution of anti-12CD staining (arrowheads) that coincides with the
position of Z discs. b) A section adjacent to that shown in a) in which anti12CD was pre-absorbed with the immunogenic peptide as described in the
Methods. Note that this treatment prevented the immunostaining seen in a).
c) Immunostaining with the pan NCAM antibody was localized at the
periphery of the myocardial cells.
d)
Anti-N-cadherin (NCD-2)
immunostaining was found in a punctate pattern at the periphery of the
myocardial cells. e) Anti-pI integrin (V2E9) immunostaining labeled the cell
periphery. Similar results were obtained with anti-pI integrin antibody JG22.
f) No staining was observed with non-immune rabbit IgG. Scale bar = 10 fl,m.
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Figure 18. Confocal Microscopic Observation of Stage 18 Chicken Heart Doubly Stained with
Anti-12CD and Anti-a-Actinin (sarcomeric) or Anti-12CD and Anti-NCAM.
Double immunostaining routinely reveals a coincidence between anti-12CD (arrowheads
in a) and a-actinin (arrowheads in b) staining in association with Z discs. Occasionally anti-aactinin staining is observed in the absence of anti-12CD staining (compare brackets in a and b). In
contrast, there is only limited overlap between anti-12CD staining (c) and staining with the pan
NCAM antibody (d). Cells in which the plane of focus captured the cell surface (regions between
broken lines) showed almost uniform staining with the pan NCAM antibody (d) whereas anti12CD staining appeared in the characteristic pattern (c). Cells cut in equatorial section (asterisks
inside) showed almost uniform circumferential staining with the pan NCAM antibody (d) and
frequently show periodic circumferential staining with anti-12CD (c). Scale bar = 10 Jlm.
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colocalize with Z discs, while N-cadherin, B1 integrin, and NCAM molecules
lacking the MSD region do not exhibit this specific association.
Confocal microscopy was used to confirm the localization of Z discs
and forms of NCAM. When tissue sections were double-labeled using anti12CD and anti-u-actinin (an actin binding protein which is a marker for Z
discs), an almost complete coincidence between the two signals was observed
(compare Figures 18, a and b). In two regions (indicated by brackets), periodic
anti-u-actinin staining was observed, but no staining with anti-12CD. These
observations suggest that most Z discs in these cells are located close to the
cell surface in the same confocal section (thickness is about 2 Jlm) as the MSD
region-containing NCAM on the cell surface. Only the occasional set of Z
discs is located either deeper in the cell, or is not associated with NCAM
molecules containing the MSD region.
When tissue sections were double-labeled using anti-12CD and the pan
NCAM antibody, cells in which the plane of focus captured the cell surface
showed almost uniform staining with the pan NCAM antibody, whereas
anti-12CD staining appeared in the characteristic striped pattern (compare
Figures 18, c and d, regions between broken lines). Only at scattered sites did
the pan-NCAM antibody show any hint of highlighting NCAM molecules
associated with Z discs. Similarly, cells in which the plane of focus cut an
equatorial

section

(Figures

18,

c

and

d,

asterisks

inside)

showed

circumferential staining which was relatively uniform with the pan NCAM
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antibody and which was frequently periodic with anti-12CD.

These results

strongly suggest that NCAM molecules containing the MSD region are
colocalized with Z discs while NCAM molecules lacking the MSD are
uniformly distributed over the entire cell surface.
Despite the fact that the anti-12CD antibody recognizes only NCAM in
Western blotting experiments, we were concerned that it might recognize an
additional protein in immunohistochemical

studies.

To rule out this

possibility, tissue sections were sequentially incubated with the pan NCAM
antibody and anti-12CD antibodies. This pretreatment with the pan NCAM
antibody totally blocked anti-12CD staining (data not shown) indicating that
the pan NCAM antibody and anti-12CD recognize the same protein, I.e.
NCAM, and that anti-12CD does not recognize non-NCAM epitope.
Structures known as 'costameres' have been identified by Pardo et al.
(1983). A costamere is defined as a structure where the cell surface proteins
are linked to subcelluar Z discs by a vinculin-containing structure. When we
examined the distribution of vinculin in tissue sections from stage 18
myocardium, however, the staining patterns observed did not coincide with
the patterns obtained with anti-12CD or anti-u-actinin (Figure 18). Additional
data (Figure 22) indicates that the association of vinculin with Z discs
(costamere assembly) has not yet occurred at stage 18.

Subcellular Localization of NCAM Splice Variants
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in Cultured Carodiomyocytes

Subcellular distribution of MSD containing NCAM specIes was also
examined in stage 18 cultured cardiomyocytes.
primary culture system that consists of over 90

We have established a

%

homogenous cardiomyocyte

cells (see the Materials and Methods section).

Dispersed myocytes show

primitive muscle contraction upon attachment to the culture dish. After one
or two days in culture/ myocytes organize their arrays of intracellular
myofibrils (shown in Figure 19). As the culture proceeds/ cells form a weblike monolayer between adjacent cells via extended myopodia.

Muscle

contraction is regular/ rhythmic/ and coordinated at this stage of culture/
which indicates completion of myofiber assembly in the cell. This in vitro
property of myofiber disassembly-and-reassembly in culture much resembles
the in vivo embryological myofibriUogenesis that occurs during mucle tissue
differentiation (58).
When NCAM was examined in cultured stage 18 myocardial cells/
anti-12CD staining was in register with Z discs (Figure 19/ a).
localization is also observed in VIVO/

Similar

in cardiomyocyte tissue of the

developing heart (Figure 17 and 18); the double immunostaining

result

shows that the MSD-containing NCAM found at Z-discs are colocalized with
a-sarcomeric actinin (compare Figure 18/ a and b). The 12CD staining pattern
also depicts the

rib-lik~

stripes at the cell surface of cultured cardiomyocytes.

54

Figure 19. Confocal Microscopic Observation of the Cultured Stage 18
Myocardial Cells.
Cells stained either with (a) anti-12CD or (b) a-(sarcomeric) actinin
antibody show a similar immunohistochemical Z-line pattern. The fact that
the MSD+ NCAM are localized at Z-discs in both single cell and in cells
involved in cell-cell contact suggests the possibility of involvement of this
NCAM in cell-ECM interactions rather than in cell-cell interactions.
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Figure 20. Immunohistochemistry of the Cultured Cardiomyocyte.
Myocardial cells were isolated from the stage 18 embryonic chicken
heart. Cells were cultured, fixed, and stained by an anti-12CD. A highly
magnified confocal microscopic image shows that the antibody precisely
depicts arrays of Z-disc actin stripes at the cell surface. The rib-like stripes
with a 2 J..lm distance detected by the anti-12CD is also typical of cytoplasmic Z
disc actin bands. Size bar = 2 J..lm.
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Figure 21. Composition and Alignment of Myofibers in Muscle Tissue.
The upper figure illustrates a basic structure of skeletal muscle, which
is shown as an actual electron microscopic image in the lower picture.
Muscle is mainly composed of two myofiber types, actin (thin line) and
myosin (thick line). Muscle contraction is achieved by the sliding motion of
actin filaments into myosin, which results in the shortening of inter-actin
distance. The Z-line represents the actin backbone which supports and
maintains the movement of myofilaments.
Figure source: L. Stryer, 1988. Biochemistry, 3rd ed.
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When this pattern was further observed at a higher magnification, each stripe
appears to coincide with the Z-discs that closely underlie the cell membrane.
In addition, the inter Z-disc distance that is typically about 2 Jlm in the mature
myofiber (23) precisely matches the distance between MSD-containing NCAM
stripes (Figure 20). The typical structure and composition of a myofiber

IS

illustrated in Figure 21.

IS

Moreover, the fact that this staining pattern

exhibited by isolated cells (Figure 19) suggests that the maintenance of this
pattern may not depend on cell-cell adhesion.

The NCAM subspecies

containing the MSD region may rather participate in cell-extracellular matrix
adhesion rather than cell-cell adhesion.
Because previous studies of costameres were performed later in
development (embryonic day 7 or later), we have prepared cardiomyocyte
culture which represents the early or late stages of myofibrillogenesis.
Myocardial cells are isolated from the stage 18 heart ventricle as described
before. When these cells are observed early (day 1 or 2) in culture, the MSDcontaining NCAM species are exclusively colocalized at Z-discs (Figure 22, b)
together with a-actinin (Figure 22, b). On the other hand, other molecules
known to be associated with Z-discs later in development,

~1

integrin (Figure

22, c), vinculin (Figure 22, e), or N-cadherin (Figure 22, f), are not yet found at
Z discs. Vinculin finally associate with Z discs later in culture (day 4) showing
the

typical striated

stripe

pattern

(Figure

23, d).

While

prevIous

immunohistochemical studies have presented rather a complete picture of
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Figure 22. Distributions of Adhesion Molecules and Cytoskeletal Proteins in
Cultured Stage 18 Myocardial Cells.
Cardiomyocytes are stained with the following antibodies: (a) anti-pan
NCAM, (b) anti-12CD, (c) anti-~1 integrin, (d) anti-a-(sarcomeric) actinin, (e)
anti-vinculin, and (f) anti-N-cadherin. Results show that the MSD+ NCAM
are the only CAM colocalizing with a-actinin at Z-discs during the early
assembly of myofibers in vitro. Size bar = 10 Jlm.
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Figure 23. Immunohistochemistry of Cultured Myocardial Cells.
Cardiomyocytes are isolated from stage 18 chicken heart, cultured for 1 or 4 days, and
immunostained for various structural components of Z-disc. At cuture day 1, cells are detected
by (a) anti-12CD, (b) anti-a-(sarcomeric) actinin, or (c) anti-vinculin. Cells are also detected by (d)
anti-vinculin at the culture day 4. Note that the MSD-containing NCAMs are colocalized at the
Z-disc earlier than vinculin.
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costamere structure which contained many cytoplasmic elements including
vinculin, actinin, and talin, our data indicates that a supposedly essential
element (vinculin) is missing from the costamere at stage 18 whereas the
MSD-positive NCAM is already present. Thus, our study indicates that the
MSD-containing NCAM has become localized to the Z-disc region even
before one of the supposedly essential structural element of costameres (i.e.,
vinculin) is assembled.
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DISCUSSION

Research Scheme to Study NCAM Containing MSD Region

The NCAM gene is composed of a large transcriptional unit including
19 major exons (Figure 2).

Three major forms of NCAM are detected in

tissues; the ld, sd, and ssd (Figure 1) variants that differ in their association to
the plasma membrane.

This structural diversity of NCAM polypeptides is

generated by an alternative RNA splicing mechanism (56, 72, 79). Overall,
three major forms of NCAM have been well identified in brain, heart, and
muscle tissues.
Heart, skeletal muscle, and skin NCAM molecules contain a MSD
insert in the extracellular portion, while this insert is not present in brain
NCAM (15, 43, 51, 72, 79). We have been particularly interested in studying
the expression of MSD insert which is spliced into the NCAM protein by a
tissue-specific mRNA splicing. The MSD insert is composed of 31 amino
acids which are encoded by four additional small exons, A-D, located between
exon 12 and 13 of the NCAM gene (Figure 3).
In

order to

detect the

MSD

sequences

contained

In

NCAM

polypeptides, we have raised two polyclonal antibodies: one is anti-12AB
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directed against the polypeptide encoded byexons 12A and B, the second is
anti-12CD against the polypeptide encoded byexons 12C and D.

We have

divided the MSD into two regions because the 3' half of MSD shares higher
homology across species than the 5' half; while the sequence of four small
exons is highly conserved between humans, rats, and mice, two of the four
chicken exons (12A and 12B) are very different in sequence from their
mammalian counterparts (51).

Therefore, two anti-MSD antibodies, each

directed against a specific sequence, would be used for a cross-species study. In
addition, these two antibodies would be able to detect if the microscale
mRNA splicing occurs between exons 12 A-D. Some studies suggest that only
exons 12A and 12D are expressed in the brain from the MSD region (26, 55,
64), whereas that all four of these small exons (12A-D) are expressed in heart,
skeletal muscle, and skin (15, 43, 51).
Based on studies using the MSD-specific antibodies, I have made the
following novel observations: 1) During heart development, all three splice
variants of NCAM (ld, sd, and ssd) that differ in their mode of attachment to
the plasma membrane are expressed both in forms containing and in forms
lacking the MSD region. 2) At the protein level, the MSD region encoded by
exons 12A, 12B, 12C, and 12D appears either to be absent or to be expressed in
its entirety, i.e. we see no evidence for alternate splicing among these four
small exons. 3) The six forms of NCAM detected in this study each change
dramatically in their expression during development.

In particular, the

percentage of the ld, sd, or ssd form expressed that is also MSD region-positive
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can vary nearly between

a and

100

%

in a temporally and spatially controlled

manner. 4) At the immunohistochemical level, forms of NCAM containing
the MSD region are specifically associated with Z discs early in heart
development

suggesting

a

role

myofibrillogenesis. 5) In cultured

for

this

regIon

cardiomyocytes, the

of

NCAM

In

MSD-containing

NCAM appear to be the earliest cell adhesion molecule that is associated with
Z discs. This suggests that MSD-expressing NCAM plays a unique role in the
J

cell membrane and myofiber interaction at very early stages of muscle
differentiation.

MSD is Present in Many NCAM Splice Variant Forms

Previous studies on forms of NCAM expressed in the developing
chicken heart revealed 150, 140, and 130 kD polypeptides (30, 51). The 130 kD
polypeptide was found to be GPI-linked to the plasma membrane and to be
the predominant form of NCAM in adult heart while the 150 and 140 kD
forms were predominant earlier in development.

Those studies also have

shown that the 180 kD and 140 kD transmembrane forms and the 120 kD GPIanchored form are present in neural tissue. Particularly, the 180 kD species
was believed to be neural tissue-specific and has never been identified in
other tissues (30).
In the present study, we have been able to resolve and unambiguously
identify six forms of NCAM during heart development (Table 2). 185 and 180
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kD polypeptides have been shown to be variants of the ld (large cytoplasmic
domain) form of NCAM because they are recognized by monoclonal antibody
4d. 155 and 145 (previously referred to as 150 and 140) kD polypeptides are
variants of the sd (small cytoplasmic domain) form of NCAM.

125

, (previously referred to as 130) and 120 kD polypeptides are variants of the ssd
(small surface domain) form of NCAM as evidenced by the fact that they are
released from membranes by PIPLC (Table 1).
higher

mol~cular

In each of these pairs, the

weight forms (185, 155, and 125 kD) are recognized by anti-

MSD region antibodies, while the lower molecular weight forms (180, 145,
and 120 kD) are not recognized by these antibodies. Thus, each splice variant
of NCAM that differs in its attachment to the plasma membrane can also be
expressed either containing or lacking the MSD region (Table 2).

This

interpretation of the identity of NCAM polypeptides is in agreement with the
studies of Yoshimi et al. (78) on the 155 kD and 145 kD forms of NCAM
expressed during skeletal muscle development.
In previous studies of forms of NCAM expressed during heart
development, the ld form observed was considered likely to be of neural
origin. The current study suggests, however, that the ld form of NCAM is
also expressed by heart tissue. First of all, the 185 and 180 kD forms of NCAM
are present at significant levels even in stage 15 (unpublished data by V.
Mironov: personal communication) chicken embryos, and these forms peak
in expression in 7 day embryos (Figure 14). If these forms of NCAM were
expressed by the cells that innervate the heart, they might be expected to
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appear later and to be maintained throughout development. Second, the 185
kD form of NCAM is recognized by anti-MSD region antibodies even though
these antibodies do not recognize any form of NCAM in the brain. Assuming
that the innervation of the heart is similar to the brain in not expressIng
forms of NCAM recognized by anti-MSD antibodies, then our data would
suggest that at least the 185 kD form of NCAM is produced within the
musculature of the heart.

It is tempting to speculate that the Id form of

NCAM may be preferentially expressed in the conduction system, given that
the polysialic moieties found on NCAM as well as the carbohydrate epitopes
recognized by monoclonal antibody HNK-l and found on neural NCAM and
other neural adhesion molecules are also preferentially expressed in this
region of the heart (47, 77).

No Heterogeneity within the MSD Sequence

Data from PCR amplification of cDNAs prepared from developing rat
heart mRNAs have suggested that alternative splicing occurs between exons
12A, 12B, 12C, and 12D, and that these four small exons are present together
in only a small percentage of NCAM mRNAs (56). Our results provide a very
different picture for NCAM molecules at the protein level. Even at the level
of CNBr fragments, we see that anti-12AB and anti-12CD recognize the same
polypeptide and that there is no apparent heterogeneity in the size of this
polypeptide. Because exons 12A and 12D are very small, we may not have
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been able to detect their alternative splicing at the protein level; however, we
should have been able to detect alternative splicing of exons 12B and 12C
because they encode sufficient mass (11 or 14 amino acids) to noticeably affect
the migration of a 45 kD CNBr fragment.
indicate that about 70

%

The PCR data of Reyes et al. (56)

of the NCAM mRNA obtained from perinatal rat

hearts lacks both exons 12B and 12C and that only 8 to 15

%

(depending on

whether ld, sd, or ssd molecules are being considered) contains both 12B and
12C. In confrast, at the protein level, we find that for ld, sd, and ssd NCAM,
forms of the molecule containing the MSD region represent at least 50

%

of

the NCAM molecules present in the heart from stage 15 embryos through
adults. Moreover, the great majority of NCAM molecules contain the MSD
region in 10 and 14-day embryos and in adults. This difference between our
results and the results of Reyes et al. (56) may be due to species differences,
differences in message stability or the ability of messages to be translated, or to
differences in the half-life of the various polypeptides.

Subcellular Localization of the MSD containing NCAM at the Z-Disc

In the heart, we find a surprising difference in the regional expression
of

forms

of

NCAM

containing

and

lacking

the

MSD

regIon

In

immunohistochemical experiments. Extracts of atrioventricular endocardial
cushion tissue included very little NCAM containing the MSD regIon.
Moreover, all the MSD region-containing NCAM in these samples may be
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derived from myocardial contamination; only the sd form of NCAM lacking
the MSD region is present in Western blots of cultured endocardial and
mesenchymal

cells

(Mironov,

unpublished observations).

V.,

R.R.

Markwald,

and

S.

Hoffman;

In contrast, extracts of ventricle showed equal

levels of NCAM molecules containing and lacking the MSD region.
Similarly,

immunohistochemical

analyses

showed

NCAM

molecules

containing the MSD region to be present in the myocardium but absent from
or present at only low levels in tissues of endocardial origin. Typically, like
other molecules involved in cell-cell adhesion, NCAM is known to be
expressed uniformly on the cell perimeter at all sites of cell-cell contact
throughout

heart

development.

Our

discovery

on

the

subcellular

distribution of NCAM molecules containing the MSD region is, therefore,
even more striking in that the MSD containing NCAM are expressed at sites
of cell surface that are distinct from the sites of NCAM species lacking this
insert; the MSD-containing NCAM are colocalized with the Z discs of
myofibrils which is detected by staining with anti-a-(sarcomeric) actinin. It is
clear that the structures recognized by anti-12CD that colocalize with Z discs
must be NCAM molecules containing the MSD region because anti-12CD
staining is blocked by preincubation of the antibody with the peptide against
which it was made or by preincubation of the tissue section with the pan
NCAM antibody (data not shown).
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We

speculate that the

structure

with which

forms

of NCAM

containing the MSD region are colocalized at the cell membrane is the
~costamere'

(48). The costamere is a structure linking the cell membrane and

subcellular Z discs and found in the striated and cardiac muscle (12)' 34/ 63)' 73).
It is a composite structure containing many cytoplasmic structural elements
including vinculin, meta-vinculin), desmin, talin, and a-actinin (34/ 63/ 73).
When these structural components are immunostained), the costamere is
..

visualized as arrays of periodic), rib-like, repeating lattice pattern beneath the
cell membrane.

A major role of the costamere is to connect the Z-discs of

myofibrils to the sarcolemma and to stabilize their association (48). The role
of costamere structure appears to be to provide more than a mechanophysical
support to the cell.

That is, costameres also play a role in transducing

extracellular signals into the cells (4).
Recent studies show that cell adhesion molecules mediating ECMcytoskeleton signalling at the cell surface play important functions in the
organization of the muscle contractile apparatus. Adhesion molecules such
as av)' a3,

~1

integrin and N-cadherin are localized to Z discs while muscle

differentiates (4)' 23, 29, 37, 44). In vitro inhibition studies demonstrate that
elimination

of certain cell to cell or cell to matrix

cardiomyocytes using N-cadherin and

~1

interactions

integrin antibodies result In

myofibril disassembly and sarcomerIC misalignment in vitro (23)' 29).
indicates that

i)

cytoskeletal contraction
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on

is highly

dependent on

This
the

organization of actin and myosIn, ii) cells respond to changes in the
extracellular milieu by dynamically reorganizing the intracellular actin
network, iii) cell adhesion molecules transduce signals received from the
ECM to the Z disc, and iv) Z discs comprise an essential element of
costameres.
Our study, however, does not detect

~1

integrin and N-cadherin in

association with Z discs at stage 18 when we do detect the MSD-positive
NCAM. That is, the MSD-containing NCAM species are already localized at
the Z-discs before other structural component of Z-discs (i.e., vinculin) and
other adhesion molecules are expressed at the same spot. These observations
make NCAM molecules containing the MSD region the earliest-appearing
cell-surface adhesion molecule detected in association with Z discs. This leads
to our speculation that the NCAM subspecies containing the MSD region may
playa key function in the earliest stages of cardiomyofibrillogenesis.

Models for the NCAM Interaction with the Muscle Z-Disc

This study provides two striking insights regarding the role of MSD
region-containing NCAM in cellular interactions and in the mechanism of its
linkage to the cytoskeleton. 1) NCAM is well known to be a myocardial cellcell adhesion molecule and is usually observed at sites of cell-cell contact in
immunohistological studies. The highlight of our study is that we find that
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the MSD-containing NCAM subspecies are uniquely associated with Z-discs.
Therefore, our observations suggest that MSD NCAM plays a special role in
the mechanical integration of muscle contractile components with the cell
membrane. Although NCAM is usually involved in cell-cell adhesion, our
observations raise the possibility that cell-cell adhesion does not playa role in
the colocalization of MSD region-containing NCAM with Z discs. In vivo,
MSD region-containing NCAM is localized in register with Z discs and not in
a uniform distribution on the cell surface or in intercalated discs as would be
expected for a molecule involved in cell-cell adhesion. In vitro, MSD regioncontaining NCAM can become colocalized with Z discs in isolated cells where
little, if any, of the cell surface is involved in cell-cell contact.

These

observations raise the possibility that MSD region-containing NCAM is
involved In cell-ECM adhesion.
electron

microscopic

This would be consistent with scanning

studies that show

collagen-containing

'struts'

of

connective tissue that interact with the myocardial cell surface In register
with Z discs (5). Previously, Walsh (75) has recognized the importance of
MSD located in a hinge region of NCAM polypeptide. He speculated that the
inclusion of a small MSD insert would transform the existing NCAM into a
more flexible structure.

This indicates that such a change may affect the

binding specificity of NCAM (75). 2) NCAM molecules containing the MSD
region are identical in the primary structure of their cytoplasmic region with
NCAM molecules lacking the MSD region.

Nevertheless, the MSD region-

containing molecules appear to interact with the cytoskeleton in a manner
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that results in their colocalization with Z discs while molecules lacking the
MSD region do not interact with the cytoskeleton in this manner.

This

suggests two models depicted in Figure 24. Either the interaction of MSD
region-containing NCAM with an ECM ligand alters the conformation of the
cytoplasmic tail of NCAM resulting in its ability to bind to a component of Z
discs (Figure 24, A) or MSD region-containing NCAM molecules can interact
with a protein in the same cell (cis ligand) that possesses the ability to bind to
a component of Z discs (Figure 24, B). Of course, more complicated models
are also possible; for example, the interaction of MSD region-containing
NCAM with a cis ligand might induce the ability of the NCAM or of the cis
ligand to interact with Z discs.

Whether MSD region-containing NCAM

interacts with an ECM ligand or a cis ligand, the interactive portion of the
MSD region may lie in its amino-acid sequence or in

the O-linked

carbohydrate [recognized by peanut lectin following neuraminidase treatment
of the molecule (75)] associated with the MSD region.
Based upon the restricted localization of MSD-containing NCAM at Zdiscs observed in heart tissue as well as in isolated cardiomyocytes, we
propose that this NCAM species playa role in muscle tissue differentiation.
More specifically, the fact that MSD-containing NCAM colocalizes with the Zdisc at very early stages of myofibrillogenesis suggests that this form of
NCAM serves as a structural backbone for the molecular assembly of Z-discs.
We also speculate that this MSD-containing NCAM plays an active role in
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NCAM
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NCA:-J ECM ligand
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Figure 24. Models for the Mechanism whereby NCAM Containing the MSD
Region is Specifically Associated with Z Discs.
The MSD region and its covalently attached O-linked oligosaccharide is
represented by a filled circle. Ligands recognizing the MSD region are
depicted with a complementary shape. In model A, the interaction of an ECM
ligand with the MSD region induces a conformational change in the
cytoplasmic tail of NCAM allowing it to bind to the Z discs. NCAM
molecules lacking the MSD region cannot bind this ECM ligand and therefore
cannot undergo the conformational change that allows them to dock in Z
discs. In model B, a cis ligand (present in the plasma membrane of the same
cell) binds both to the MSD region and to the Z disc. NCAM molecules
lacking the MSD region do not bind to this cis ligand and do not become
associated with Z discs.
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transmembrane signal transduction via its interaction with components of Zdiscs.
The current study demonstrates the feasibility and utility of uSIng
antibodies against alternatively spliced regions in NCAM to evaluate their
identity and distributions in vivo.

The existence of the MSD region in

NCAM was deduced from molecular biological studies.

However, such

studies did not indicate precisely which mRNAs detected on Northern blots
using

MSD

region-specific probes encode which

NCAM

polypeptides

observed on Western blots. Molecular biological studies also did not and
cannot indicate the subcellular distribution of forms of NCAM containing the
MSD region. The antibodies prepared in the current study have allowed the
identification and characterization on Western blots of the forms of NCAM
containing the MSD region. Moreover, these antibodies have allowed us to
make the striking observation that forms of NCAM containing the MSD
region are colocalized with Z discs and thus are likely to be involved in
myofibrillogenesis.

Antibodies specific for other splice variants of NCAM

(e.g. ld and ssd forms and forms containing the VASE insert) may be equally
useful for determining the distribution in vivo of particular forms of NCAM
and thereby suggesting specialized functions for each of these forms.

Future Studies on the NCAM Containing MSD
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In the current study, we have prepared antibodies against two
oligopeptides that together comprise the MSD region of chicken NCAM.
These antibodies have allowed us to analyze the expression of forms of
NCAM in heart development.

We find that all ld, sd, and ssd forms of

NCAM can contain or lack this MSD insert. During heart development, six
various forms of NCAM dramatically change their temporal and spatial
patterns of expression.
containing· the

MSD

Specially, expression modes of NCAM speCIes
sequence

are

precisely

correlated

to

myofiber

differentiation of heart. These findings are reproduced in the cardiomyocyte
culture

making

MSD-positive

NCAM

the earliest adhesion

molecule

localized at the Z disc region. We therefore propose new models of NCAM
interaction and suggest that the MSD-containing NCAM species playa role in
myofibrillogenesis.
Finally, I would like to suggest future follow-up studies for NCAM
containing the MSD insert. i) Transgenic or gene knock-out experiment: As
for the loss of MSD function, a mouse can be produced via targeted disruption
of the MSD sequence in NCAM (knock-out).

Likewise, a knock-in mouse

with over (redundant)-expressed MSD in NCAM species can be created.
These studies would be invaluable in understanding the role of MSD. ii) The
mechanism of MSD splicing: Though the MSD expression is highly tissuespecific, how its mRNA splicing is regulated at these tissues is not known.
This study would be important in understanding the molecular genetics and
the diversity of NCAM .
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